Re: Month 10

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Month 10

in response to

Re: Month 10

SanFrancisco99

posted on Apr 18, 2017 10:55AM

SF - From slide 17 of the June 20, 2016 Quarterly Update there are just 3 patients per cohort unless there are issues which would cause an additional 3 patients to be recruited.

tada

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply